Meta-analysis of Nonsteroidal Anti-Inflammatory Drug Intake and Prostate Cancer Risk

Xiao Wang,Yi-wei Lin,Jian Wu,Yi Zhu,Xiang-lai Xu,Xin Xu,Zhen Liang,Zheng-hui Hu,Shi-qi Li,Xiang-yi Zheng,Li-ping Xie
DOI: https://doi.org/10.1186/1477-7819-12-304
2014-01-01
World Journal of Surgical Oncology
Abstract:Background: Epidemiological studies of the association between nonsteroidal anti-inflammatory drug (NSAID) intake and the risk of prostate cancer still remain controversial. Therefore, we conducted a meta-analysis to evaluate the potential association between NSAID intake and prostate cancer risk. Methods: Eligible studies were retrieved by both computerized searches and reviews of references. Subgroup analyses on country and design of study were also performed. Random or fixed-effect models were used to pool estimates of odds ratios (ORs) with 95% confidence intervals (CIs). Results: We observed that the intake of aspirin was associated with a marginally decreased risk of prostate cancer (OR =0.95, 95% CI =0.93 to 0.98). A similar result was found between nonaspirin NSAIDs and prostate cancer risk (OR =0.94, 95% CI =0.90 to 0.98). However, a positive relation between all-NSAID intake and prostate cancer risk was observed (OR =1.18, 95% CI =1.15 to 1.22). Conclusions: We observed a marginally inverse correlation between the intake of aspirin and prostate cancer risk. On the contrary, a positive relationship between all-NSAID intake and prostate cancer was detected. Further research needs to be conducted to better clarify potential biological mechanisms.
What problem does this paper attempt to address?